<ѻý>Drug-Free Obesity Capsule Cleared; FDA Reviews Acromegaly Tx; Stem Cells Reverse T1Dѻý> News and commentary from the endocrinology world Oct 01, 2024
<ѻý>Food Retention Risk Low for GLP-1 Users When Endoscopy Is Combined With Colonoscopyѻý> Bowel preparation protocols appeared protective in small study Oct 01, 2024
<ѻý>The Data Are Clear: Patients Regain Weight After Stopping GLP-1 Drugsѻý> Other than staying on drug, there's no evidence-based strategy to maintain weight loss Sep 26, 2024
<ѻý>'Stop Ripping Us Off': Senate Goes After Ozempic-Maker Over Pricingѻý> Novo Nordisk needs to cut prices, says Sen. Bernie Sanders Sep 24, 2024
<ѻý>One-Year CGM Cleared; Osteoporosis Lawsuits Revived; Chemicals and Early Pubertyѻý> News and commentary from the endocrinology world Sep 24, 2024
<ѻý>Severe Obesity on the Rise in the U.S.ѻý> Nearly 10% of those surveyed reported severe obesity Sep 24, 2024
<ѻý>What Factors Predict Clinically Meaningful Weight Loss With GLP-1 Agonists?ѻý> Researcher discusses weight outcomes for those taking semaglutide or liraglutide Sep 16, 2024 video
<ѻý>Early Data for GLP-1 Pill; FAERS Tirzepatide Reports; AI Diabetes Voice Screeningѻý> More noteworthy research from the EASD 2024 meeting Sep 13, 2024
<ѻý>Direct-to-Consumer Drugs: Big Pharma's Digital Health Playѻý> Regulators will need to closely watch this new frontier Sep 13, 2024
<ѻý>Tirzepatide Yields Greater Weight Loss in Women Than Menѻý> But significant weight loss reported for both Sep 12, 2024
<ѻý>Liraglutide Helped Cut BMI in Kids With Obesity as Young as 6ѻý> Saxenda group six times more likely to lose at least 5% of BMI Sep 10, 2024
<ѻý>FreeStyle Libre 3 Sensor Class I Recall; Second OTC CGM Cleared; Weekly Insulin Winѻý> News and commentary from the endocrinology world Sep 09, 2024
<ѻý>New Studies Fuel Debate Over GLP-1 Drugs and Suicide Riskѻý> No link found in nationwide data from Sweden and Denmark and in analysis of STEP trials Sep 03, 2024
<ѻý>Meat Types and T2D; Semaglutide in Heart Failure; Acromegaly at the Paralympicsѻý> News and commentary from the endocrinology world Sep 03, 2024
<ѻý>Wegovy Protects Against Deadly COVID Casesѻý> Non-cardiovascular benefits observed in SELECT trial Aug 30, 2024
<ѻý>T1D Stem Cell Success Story; Lilly's Discount Tirzepatide Vials; Stelo Now Availableѻý> News and commentary from the endocrinology world Aug 27, 2024
<ѻý>Intermittent Fasting in Teens With Obesity Matches Calorie Restrictionѻý> Similar improvements in weight loss and mental health in randomized trial Aug 26, 2024
<ѻý>Semaglutide Has Disproportionate Suicidality Signal, Analysis Findsѻý> Reports of suicidal ideation higher when compared to other drugs in WHO database Aug 20, 2024
<ѻý>Zepbound Can Prevent Diabetes; Menopause and Cognition; Tandem's Insulin Pump Updateѻý> News and commentary from the endocrinology world Aug 20, 2024
<ѻý>Researchers Hit the Road to Learn Why CVD and COPD Are Rampant in the Rural Southѻý> "No race is spared, although people of color fare worse," says project leader Aug 19, 2024
<ѻý>Disposable CGM Approved; Mounjaro Tied to Reduced Mortality; Benefits of Ligninsѻý> News and commentary from the endocrinology world Aug 13, 2024
<ѻý>Eating Disorders After GLP-1s? Tirzepatide for Heart Failure; Soda Taxes and BMIѻý> News and commentary from the endocrinology world Aug 06, 2024
<ѻý>Prescription-Free Online Semaglutide Is Risky Businessѻý> Over 40% of pharmacy sites offering GLP-1 drug without a script are known to operate illegally Aug 05, 2024
<ѻý>Aerosmith Retires After Injury; All Zepbound Doses Now Available; Guacamole Recalledѻý> Health news and commentary gathered by ѻý staff Aug 05, 2024
<ѻý>Intermittent Fasting May Improve Memory, Executive Function, Early Trial Suggestsѻý> Exploratory study lays groundwork for larger trials to evaluate brain health Aug 04, 2024
<ѻý>New Firearm Injury Numbers; Another Indication for Semaglutide?ѻý> Also in TTHealthWatch: bilateral mastectomy for breast cancer Aug 03, 2024 podcast
<ѻý>Semaglutide May Help Smokers Quit, Study Suggestsѻý> Use for diabetes tied to fewer medical visits for tobacco use disorder versus other antidiabetics Jul 30, 2024
<ѻý>Faulty FreeStyle Libre 3 Sensors; Endocrine Society Merger; More Levemir Pushbackѻý> News and commentary from the endocrinology world Jul 30, 2024
<ѻý>FDA Warns of Overdoses With Compounded Semaglutideѻý> Multi-dose vials pose complications for self-administration Jul 29, 2024
<ѻý>Maternal Obesity Linked to Sudden Unexpected Infant Deathѻý> Researchers found a dose-dependent link but causal mechanism remains unclear Jul 29, 2024
<ѻý>Early-Stage GLP-1 Win in Obesity; An Argument for BMI's Value; Insulin Supply Issuesѻý> News and commentary from the endocrinology world Jul 23, 2024
<ѻý>People Without Diabetes Make Up Growing Share of GLP-1 Usersѻý> Approximately one-fourth of new users in 2023 did not have type 2 diabetes Jul 22, 2024
<ѻý>Few Stick With Ozempic; Pfizer Making Daily GLP-1; Once-Weekly Insulin Turned Downѻý> News and commentary from the endocrinology world Jul 16, 2024
<ѻý>We've Been Here Before: The Politicization of Drug Pricingѻý> Ensuring medication access does not have to come at the cost of innovation Jul 16, 2024
<ѻý>Shedding Criticisms: The Real Weight of Misunderstanding Obesityѻý> Stigma and misconceptions create barriers to medication uptake Jul 14, 2024
<ѻý>New Investigational Fertility Pill; Biden Wants Lower GLP-1 Prices; BVO to Be Bannedѻý> News and commentary from the endocrinology world Jul 09, 2024
<ѻý>Tirzepatide Bests Semaglutide for Real-World Weight Lossѻý> Injectables were compared at doses approved for type 2 diabetes Jul 08, 2024
<ѻý>Popular Diabetes Drug Class Lowered Risk of 10 Obesity-Associated Cancersѻý> For people with diabetes, cancer risks were reduced with GLP-1s versus insulin Jul 05, 2024